Brightflow Medical

France - ParisBiotechnology1 H-1B visas (FY2023)

Focus: Brightflow Medical is a Paris-based biotechnology company founded in 2020, specializing in heart failure devices within the cardiovascular and metabolic disease space. The company remains early-stage with minimal disclosed operational scale.

Cardiovascular Metabolic Diseases

Profile data last refreshed 3h ago · AI intelligence enriched Yesterday

Total Funding

$50M

Open Jobs

About Brightflow Medical

AI assessmentNot Hiring

No open roles listed right now. Follow Brightflow Medical to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

0 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Key Products

FLUTICASONE PROPIONATE

Hay fever and upper respiratory allergies

Post-LOE

A post-LOE corticosteroid ointment for allergic conditions; therapeutic area misalignment with stated heart failure device specialty suggests possible portfolio acquisition or legacy asset.

Products & Portfolio (1)

Help build intelligence for Brightflow Medical

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Early-stage device innovator in high-unmet-need cardiovascular space (heart failure) with potential for significant clinical impact
Based in Paris, a growing biotech hub with access to European regulatory pathways and talent
H1B sponsorship demonstrated (1 approval in 2023), suggesting openness to international hiring

Watch Out For

No active job openings recorded; hiring appears dormant or not tracked in open channels
Lack of public pipeline data, clinical trial activity, or funding transparency raises questions about development velocity and financing stability
Incomplete financial and operational disclosure limits visibility into growth trajectory, cash runway, and strategic direction

Generated by Claude from Brightflow Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Founded: 2020

Portfolio: 1 approved product

Top TAs: Respiratory

H-1B (2023): 1 approval

Portfolio Health

Post-LOE1 (100%)

1 total products

Therapeutic Area Focus

Respiratory

1 marketed

Marketed

Pipeline

Visa Sponsorship

Sponsors Work Visas

H-1B Petitions (FY2023)

Approved

Denied

100%

Rate

Source: USCIS H-1B Employer Data Hub

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo